Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3845154

Cl.NC(C=C(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 2/20 0.41
SLC6A2 known ✓ P23975 1/20 0.38
SLC6A4 known ✓ P31645 1/20 0.38
SLC6A3 known ✓ Q01959 1/20 0.38
ADRA2A known ✓ P08913 1/20 0.38
ADRA2C known ✓ P18825 1/20 0.38
F2 P00734 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 2/20 0.38
HIF1A Q16665 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 1/20 0.38
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
BLM P54132 1/20 0.37
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5967505 0.98 DPP4 (0.42) DPP4F2ALDH1A1LMNAADRA2A
SCHEMBL11413560 0.79 DPP4 (0.41) DPP4F2ALDH1A1LMNAADRA2A
SCHEMBL16615163 0.79 DPP4 (0.41) DPP4F2ALDH1A1LMNAADRA2A
SCHEMBL10613825 0.76 L3MBTL1 (0.41) DPP4F2ALDH1A1LMNATDP1
SCHEMBL1794030 0.76 L3MBTL1 (0.41) DPP4F2ALDH1A1LMNATDP1
Hydrochloric Acid SCHEMBL2996840 0.75 L3MBTL1 (0.38) ALDH1A1SLC6A2SLC6A4SLC6A3LMNA
Hydrochloric Acid SCHEMBL3838251 0.75 TDP1 (0.38) ALDH1A1SLC6A2SLC6A4SLC6A3LMNA
SCHEMBL27756818 0.75 F2 (0.41) DPP4F2ALDH1A1LMNAADRA2A
SCHEMBL563813 0.74 LMNA (0.45) DPP4F2ALDH1A1LMNAADRA2A
SCHEMBL15004145 0.73 ADRA2C (0.39) DPP4F2ALDH1A1LMNAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5658671-A ARTICLE COATED WITH COMPOSITION COMPRISING FLUOROELASTOMER, QUATERNARY AMMONIUM OR PHOSPHONIUM ACCELERATOR, POLYOL, ACID ACCEPTOR, OIL-SOLUBLE CHELATING AGENT, ORGANIC SOLVENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-08-19 US claimed
US-5451625-A FOR USE IN THE PREPARATION OF AUTOMOTIVE GASKETS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-09-19 US claimed
EP-0574319-A1 Fluoroelastomer coating composition MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-12-15 EP claimed
EP-1682609-B1 METHOD OF MODIFYING A FLUOROPOLYMER AND ARTICLES THEREBY 3M INNOVATIVE PROPERTIES CO (US) 2015-03-11 EP disclosed
EP-2014703-B1 Process of preparing a composite article 3M INNOVATIVE PROPERTIES CO (US) 2009-12-09 EP disclosed
EP-2014703-A1 Method of modifying a fluoropolymer and articles thereby 3M Innovative Properties Company (US) 2009-01-14 EP disclosed
EP-1453896-B1 PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES CO (US) 2008-04-09 EP disclosed
EP-1461376-B1 IMPROVED PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES CO (US) 2006-12-20 EP disclosed
US-7140413-B2 Method of modifying a fluoropolymer and articles thereby 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-11-28 US disclosed
EP-1682609-A1 METHOD OF MODIFYING A FLUOROPOLYMER AND ARTICLES THEREBY 3M Innovative Properties Company (US) 2006-07-26 EP disclosed
US-20060029812-A1 Method of modifying a fluoropolymer and articles thereby 3M INNOVATIVE PROPERTIES COMPANY 2006-02-09 US disclosed
US-6752894-B2 EXPOSURE TO ACTINIC RADIATION; DISCOLORATION INHIBITION; OXIDATION RESISTANCE 3M INNOVATIVE PROPERTIES COMPANY 2004-06-22 US disclosed
US-20030159915-A1 Process for modifying a polymeric surface 3M INNOVATIVE PROPERTIES COMPANY 2003-08-28 US disclosed
US-20030162022-A1 Process for modifying a polymeric surface 3M INNOVATIVE PROPERTIES COMPANY 2003-08-28 US disclosed
WO-2003051966-A1 IMPROVED PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-26 WO disclosed
WO-2003051965-A1 PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-26 WO disclosed
EP-0574319-B1 Fluoroelastomer coating composition DYNEON LLC (US) 1998-01-21 EP disclosed
US-5658671-A ARTICLE COATED WITH COMPOSITION COMPRISING FLUOROELASTOMER, QUATERNARY AMMONIUM OR PHOSPHONIUM ACCELERATOR, POLYOL, ACID ACCEPTOR, OIL-SOLUBLE CHELATING AGENT, ORGANIC SOLVENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-08-19 US disclosed
US-5451625-A FOR USE IN THE PREPARATION OF AUTOMOTIVE GASKETS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-09-19 US disclosed
EP-0574319-A1 Fluoroelastomer coating composition MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030159915-A1 Process for modifying a polymeric surface FSCN1, FLNA, FLNB DPP4 4786/4885SLC6A2 2939/4885SLC6A4 1837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.